Efficacy of Replication-Defective Adenovirus-Vectored Vaccines: Protection Following Intramuscular Injection Is Linked to Promoter Efficiency in Muscle Representative Cells
- 1 November 1997
- Vol. 238 (2) , 327-335
- https://doi.org/10.1006/viro.1997.8842
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Mammalian cell lines can be efficiently established in vitro upon expression of the SV40 large T antigen driven by a promoter sequence derived from the human vimentin genePublished by Wiley ,2012
- Immunobiology of pseudorabies (Aujeszky's Disease)Veterinary Immunology and Immunopathology, 1996
- Investigation of promoter function in human and animal cells infected with human recombinant adenoviruses expressing rotavirus antigen VP7scJournal of General Virology, 1995
- Recombinant Adenoviruses as VaccinesBiologicals, 1995
- Facilitated DNA inoculation induces anti-HIV-1 immunity in vivoVaccine, 1994
- The immunobiology of muscleImmunology Today, 1994
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccineJournal of General Virology, 1990
- Identification of the pseudorabies virus glycoprotein gp50 as a major target of neutralizing antibodiesArchiv für die gesamte Virusforschung, 1988
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977